Robert N. Shapiro’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-123
Closed -$8K 766
2014
Q1
$8K Sell
123
-339
-73% -$21.9K ﹤0.01% 639
2013
Q4
$27K Sell
462
-92
-17% -$5K ﹤0.01% 552
2013
Q3
$29K Buy
554
+6
+1% +$301 0.01% 710
2013
Q2
$26K Buy
+548
New +$27.9K 0.01% 693

Other funds holding AZN

Robert N. Shapiro's AZN Position: Q2 2014 in Review

Robert N. Shapiro sold out of AstraZeneca (AZN) in Q2 2014, closing a stake of 123 shares — an estimated $8K sold.

Robert N. Shapiro first reported a position in AZN in Q2 2013 and held it in 4 quarters. The position peaked at $29K in Q3 2013. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

  • Robert N. Shapiro reported no remaining AstraZeneca position as of Q2 2014 after selling out during the quarter.
  • Robert N. Shapiro sold 123 AstraZeneca shares in Q2 2014, an estimated $8K.
  • Robert N. Shapiro first reported a position in AstraZeneca in Q2 2013 and held it in 4 quarters.
  • Robert N. Shapiro's AstraZeneca position peaked at $29K in Q3 2013.
  • 419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on Robert N. Shapiro's 13F filing for Q2 2014, filed 11 Sep 2014.